UBS analyst Kavya Deshpande maintained a Buy rating on bioMerieux (0RUG – Research Report) today and set a price target of €138.00. The ...
In a report released yesterday, Owen Birrell from RBC Capital maintained a Hold rating on Sims (SMUPF – Research Report), with a price target ...
UK asset managers face structural and cyclical challenges. The shift from active to passive investing has been unfolding for many years and is well documented. When interest rates began to climb in ...
Qantas has soared to a $1.385bn half year underlying profit for the six months to December 31, 2024, its second best result ...
The operating margin at the engines division is set to head north because of better RRSP cash flows, the end of a lengthy restructuring programme (which should be finalised this year), and a ...
ASX-listed payments stocks Tyro, Cuscal and EML reported interim results on Wednesday. All three rose on the market on ...
One of Australia’s largest investors says there are better opportunities in the UK and Europe than in Australia and the US, ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
The latest Market Talks covering the Auto and Transport sector. Published exclusively on Dow Jones Newswires at 4:20 ET, ...
The general mood among these heavyweight investors is divided, with 47% leaning bullish and 41% bearish. Among these notable options, 8 are puts, totaling $399,736, and 9 are calls, amounting to ...
The FTSE 100 closed in positive territory on Tuesday, although well off early highs, as a marked drop in US consumer confidence knocked Wall Street. The FTSE 100 index closed up 9.69 points, 0.1%, at ...
3don MSN
Find insight on Smith & Nephew, Raffles Medical Group and more in the latest Market Talks covering the Health Care sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results